Proposed sale of 3,469 SGRY shares; insider sold 7,736 shares (SGRY)

Rhea-AI Filing Summary

Surgery Partners, Inc. reported proposed dispositions related to equity compensation: 3,469 shares of common stock tied to an equity vesting event dated 03/04/2026. The filing also shows a prior sale of 7,736 common shares by Danielle Burkhalter on 03/06/2026.

Insights

Securities Compliance Counsel

Filing records proposed sale from vested equity and a recent insider sale.

The entry lists 3,469 common shares associated with an equity vesting event dated 03/04/2026; this is a notice of proposed disposition under resale rules.

It also records a prior disposition of 7,736 shares by Danielle Burkhalter on 03/06/2026. Timing, method, and cash‑flow treatment for the proposed sale are not provided in the excerpt.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	3469	44507.27	129419836	03/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	03/04/2026	equity vesting	Surgery Partners, Inc.			3469	03/04/2026	equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Danielle Burkhalter 5167 Miller Lake Road Culleoaka TN 38451	common	03/06/2026	7736	105238

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the SGRY Form 144 disclose?

The filing discloses a proposed disposition of 3,469 common shares tied to an equity vesting event on 03/04/2026, and a prior sale of 7,736 shares by Danielle Burkhalter on 03/06/2026.

Who previously sold shares according to the SGRY excerpt?

The excerpt shows a sale by Danielle Burkhalter of 7,736 common shares on 03/06/2026. The filing lists her address and sale quantity but does not disclose proceeds or sale method.

Are the proposed sale's proceeds shown in the SGRY filing?

No proceeds amount or sale method is included in the provided excerpt. The entry only lists the 3,469 shares associated with an equity vesting event on 03/04/2026 without cash‑flow details.

Does the filing state how the 3,469 SGRY shares will be sold?

The filing labels the item as equity vesting and a proposed disposition but does not specify the distribution method (block trades, brokerage, private sale) or any conditional qualifiers in the excerpt.